Cellular effects of hydroxyurea in Hb SC disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Hb S polymerizes in high‐density Hb SC disease erythrocytes. We hypothesized that hydroxyurea — perhaps independent of increasing Hb F — might reduce the density of these cells. Six Hb SC disease patients were given 1000 mg of hydroxyurea daily and blood counts, cell volumes, and cell density were followed for 12 months. There was an increase in MCV and reticulocyte MCV. A fall in absolute reticulocyte counts, high‐staining (‘stress’) reticulocytes, serum bilirubin, and an increase in the ratio of mature red cell haemoglobin to reticulocyte haemoglobin, coupled with a rise in the haematocrit inferred a decrease in haemolysis and ‘stress erythropoiesis’. An improvement in cell hydration was suggested by a reduction in reticulocyte mean cell haemoglobin concentration (CHCMr), red cells and reticulocytes with CHCM > 38, and decreased dense cell counts estimated by phthalate ester and Percoll‐Larex gradients. After 4–5 months treatment, Hb F rose in a few patients but the overall difference in pre‐ and post‐treatment Hb F was not significant. A decline in cell density should diminish the polymerization tendency of Hb S in Hb SC disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 1×
“…1991; Charache et al, 1992; Rodgers et al, 1990), but this disorder is associated with considerable morbidity and increased mortality, especially after the age of 30 years (Kinney & Ware, 1994; Platt et al, 1994; Lutty & Goldberg, 1994; Milner et al, 1991; Castro et al, 1994; Platt et al, 1991).”
BackgroundSelf-citationPain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546 · cited 2×
“Hb SC disease patients live longer than those with sickle cell anaemia and have fewer pain episodes (Platt et al, 1991; Charache et al, 1992; Rodgers et al, 1990), but this disorder is associated with considerable morbidity and increased mortality, especially after the age of 30 years (Kinney &…”
Background
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Self-citationStuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Self-citationManagement of Sickle Cell Disease
Steinberg, M. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401307 · Cited by 604
Self-citationHow I use hydroxyurea to treat young patients with sickle cell anemia
Ware, R. E. (2010) · Blood · doi:10.1182/blood-2009-04-146852 · Cited by 396
Metadata
- Authors
- Steinberg, M. H., Nagel, R. L., & Brugnara, C.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 98
- Issue
- 4
- Pages
- 838-844
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2072783023
- Cited by
- 62
- References
- 2
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cellular effects of hydroxyurea in Hb SC disease. https://app.cochat.ai/papers/10.1046/j.1365-2141.1997.3173132.x
- The paper
- Steinberg, M. H., Nagel, R. L., & Brugnara, C. (1997). Cellular effects of hydroxyurea in Hb SC disease. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1997.3173132.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.